What does CUSIP 09061G101 represent in this 13F holders report?

CUSIP 09061G101 is the security identifier for BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock used to aggregate holder disclosures.

How many institutions held BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in Q4 2016?

404 institutional investors reported BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock for Q4 2016. Use the holders table for investor-level position and value details.

BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)

CUSIP: 09061G101

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class: Equity / Common Stock
Shares outstanding: 192,975,286
Total 13F shares: 169,392,815
Share change: +900,807
Total reported value: $14,033,179,313
Put/Call ratio: 124%
Price per share: $82.84
Number of holders: 404
Value change: +$56,824,379
Number of buys: 195
Number of sells: 203

Quarterly Holders Quick Answers

What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2017
Previous quarter: Q3 2016

Recent filing periods for CUSIP 09061G101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	10%	20,216,215	$1,870,404,000	—	30 Sep 2016	13F
VANGUARD GROUP INC	13F	Company	6.3%	12,230,286	$1,131,547,000	—	30 Sep 2016	13F
SANDS CAPITAL MANAGEMENT, LLC	13F	Company	5.3%	10,221,282	$945,673,000	—	30 Sep 2016	13F
FMR LLC	13F	Company	5.2%	10,079,541	$932,559,000	—	30 Sep 2016	13F
JENNISON ASSOCIATES LLC	13F	Company	5%	9,702,200	$897,648,000	—	30 Sep 2016	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	3.7%	7,108,129	$657,644,000	—	30 Sep 2016	13F
BAKER BROS. ADVISORS LP	13F	Company	2.5%	4,806,483	$444,696,000	—	30 Sep 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	2.1%	4,131,259	$382,224,000	—	30 Sep 2016	13F
BlackRock Fund Advisors	13F	Company	2.1%	4,049,472	$374,657,000	—	30 Sep 2016	13F
JPMORGAN CHASE & CO	13F	Company	1.9%	3,701,061	$342,548,000	—	30 Sep 2016	13F
STATE STREET CORP	13F	Company	1.9%	3,635,047	$336,320,000	—	30 Sep 2016	13F
Temasek Holdings (Private) Ltd	13F	Company	1.8%	3,472,712	$321,295,000	—	30 Sep 2016	13F
Invesco Ltd.	13F	Company	1.6%	3,059,368	$283,054,000	—	30 Sep 2016	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.3%	2,587,129	$239,361,000	—	30 Sep 2016	13F
WELLS FARGO & COMPANY/MN	13F	Company	1.2%	2,381,816	$220,366,000	—	30 Sep 2016	13F
OppenheimerFunds, Inc.	13F	Company	1.1%	2,164,153	$200,228,000	—	30 Sep 2016	13F
Bank of New York Mellon Corp	13F	Company	1.1%	2,092,523	$193,600,000	—	30 Sep 2016	13F
Palo Alto Investors LP	13F	Company	0.93%	1,790,899	$165,694,000	—	30 Sep 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.85%	1,649,287	$152,593,000	—	30 Sep 2016	13F
FRANKLIN RESOURCES INC	13F	Company	0.85%	1,646,896	$152,374,000	—	30 Sep 2016	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.85%	1,644,829	$152,180,000	—	30 Sep 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.8%	1,550,912	$143,484,000	—	30 Sep 2016	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.78%	1,511,704	$139,857,000	—	30 Sep 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.72%	1,387,191	$128,343,000	—	30 Sep 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.69%	1,331,800	$123,218,000	—	30 Sep 2016	13F
NORTHERN TRUST CORP	13F	Company	0.67%	1,294,318	$119,750,000	—	30 Sep 2016	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.66%	1,268,066	$117,321,000	—	30 Sep 2016	13F
WADDELL & REED FINANCIAL INC	13F	Company	0.61%	1,177,946	$108,983,000	—	30 Sep 2016	13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	13F	Company	0.61%	1,176,075	$108,810,000	—	30 Sep 2016	13F
ORBIMED ADVISORS LLC	13F	Company	0.6%	1,151,900	$106,574,000	—	30 Sep 2016	13F
TCW GROUP INC	13F	Company	0.6%	1,149,018	$106,308,000	—	30 Sep 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.59%	1,138,621	$105,303,000	—	30 Sep 2016	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.56%	1,081,092	$100,024,000	—	30 Sep 2016	13F
BlackRock Group LTD	13F	Company	0.54%	1,040,015	$96,221,000	—	30 Sep 2016	13F
CITADEL ADVISORS LLC	13F	Company	0.5%	973,285	$90,048,000	—	30 Sep 2016	13F
NORGES BANK	13F	Company	0.51%	987,380	$87,251,000	—	30 Sep 2016	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.46%	894,843	$82,791,000	—	30 Sep 2016	13F
Senator Investment Group LP	13F	Company	0.44%	850,000	$78,642,000	—	30 Sep 2016	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.42%	815,068	$75,410,000	—	30 Sep 2016	13F
Alyeska Investment Group, L.P.	13F	Company	0.42%	808,248	$74,779,000	—	30 Sep 2016	13F
Blue Ridge Capital, L.L.C.	13F	Company	0.41%	800,000	$74,016,000	—	30 Sep 2016	13F
Clearbridge Investments, LLC	13F	Company	0.38%	725,445	$67,118,000	—	30 Sep 2016	13F
PFM Health Sciences, LP	13F	Company	0.37%	722,738	$66,868,000	—	30 Sep 2016	13F
Tekla Capital Management LLC	13F	Company	0.37%	710,145	$65,703,000	—	30 Sep 2016	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.36%	700,388	$64,800,000	—	30 Sep 2016	13F
Legal & General Group Plc	13F	Company	0.33%	644,337	$59,614,000	—	30 Sep 2016	13F
Allianz Asset Management GmbH	13F	Company	0.33%	633,614	$58,689,000	—	30 Sep 2016	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.32%	625,121	$57,836,000	—	30 Sep 2016	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.32%	625,000	$57,825,000	—	30 Sep 2016	13F
CHARTWELL INVESTMENT PARTNERS, LLC	13F	Company	0.32%	619,625	$57,328,000	—	30 Sep 2016	13F

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q4 2016

As of 31 Dec 2016, BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by 404 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 169,392,815 shares. The largest 10 holders included Capital Research Global Investors, VANGUARD GROUP INC, SANDS CAPITAL MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, FMR LLC, PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and STATE STREET CORP. This page lists 404 institutional shareholders reporting positions in this security for the Q4 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders

419

Q4 2016 holders

404

Holder diff

-15

Investor	Q3 2016 Shares	Q4 2016 Shares	Share Diff	Share Chg %	Q3 2016 Value $	Q4 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.